Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Aoucheta
D. Aoucheta
Ferring Pharmaceuticals
Ulcerative colitis
Mesalazine
Medicine
Internal medicine
Gastroenterology
3
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
2013
Alimentary Pharmacology & Therapeutics
Bernard Flourié
H. Hagege
Gilbert Tucat
D Maetz
Xavier Hébuterne
J. Kuyvenhoven
T G Tan
Marie Pierik
Ad Masclee
O. Dewit
Chris Probert
D. Aoucheta
Show All
Source
Cite
Save
Citations (43)
P184 Once-daily versus twice-daily mesalazine for mild to moderately active ulcerative colitis: Mucosal healing and early response data from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
2012
Journal of Crohns & Colitis
Marie Pierik
H. Hagege
Gilbert Tucat
Ad Masclee
O. Dewit
Chris Probert
Per Broberg
D. Aoucheta
Show All
Source
Cite
Save
Citations (4)
P183 Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
2012
Journal of Crohns & Colitis
Bernard Flourié
H. Hagege
Gilbert Tucat
Ad Masclee
O. Dewit
Chris Probert
Per Broberg
D. Aoucheta
Show All
Source
Cite
Save
Citations (4)
1
map